BioCorRx Inc. (BICX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 350K 700K 1.1M Q4 '15: 924.7K Q1 '16: 879.7K Q2 '16: 609.8K Q3 '16: 659.2K Q4 '16: 701.8K Q1 '17: 605.6K Q2 '17: 628.2K Q3 '17: 608.2K Q4 '17: 657.3K Q1 '18: 670.8K Q2 '18: 558.9K Q3 '18: 489.9K Q4 '18: 376.7K Q1 '19: 294.2K Q2 '19: 261.5K Q3 '19: 229.5K Q4 '19: 240.3K Q1 '20: 211.9K Q2 '20: 179.6K Q3 '20: 162.8K Q4 '20: 122.6K Q1 '21: 95.8K Q2 '21: 77.9K Q3 '21: 56.9K Q4 '21: 48.3K Q1 '22: 58.7K Q2 '22: 59K Q3 '22: 144.6K Q4 '22: 213.8K Q1 '23: 233.8K Q2 '23: 237.4K Q3 '23: 153.1K Q4 '23: 89.2K Q1 '24: 52.3K Q2 '24: 36.7K Q3 '24: 26.6K Q4 '24: 7.7K Q1 '25: 138.9K Q2 '25: 313.1K Q3 '25: 948.4K Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Gross Profit TTM

0 500K 1M 1.5M Q4 '11: 371.3K Q1 '12: 482.1K Q2 '12: 360.6K Q3 '12: 143.2K Q4 '12: 465.7K Q1 '13: 672.2K Q2 '13: 1M Q3 '13: 1.3M Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13

Operating Income TTM

-9M -6M -3M 0 3M 6M 9M Q3 '16: -2M Q4 '16: -2.2M Q1 '17: -2.3M Q2 '17: -2.6M Q3 '17: -2.8M Q4 '17: -2.9M Q1 '18: -3M Q2 '18: -3M Q3 '18: -3.7M Q4 '18: -4.6M Q1 '19: -5.6M Q2 '19: -6.4M Q3 '19: -5.9M Q4 '19: -5.6M Q1 '20: -5.6M Q2 '20: -6.2M Q3 '20: -7.3M Q4 '20: -7.5M Q1 '21: -7.6M Q2 '21: -6.4M Q3 '21: -5.9M Q4 '21: -5.5M Q1 '22: -5.1M Q2 '22: -5.5M Q3 '22: -4.8M Q4 '22: -4.7M Q1 '23: -4.6M Q2 '23: -4.2M Q3 '23: -4.2M Q4 '23: -3.8M Q1 '24: -3.7M Q2 '24: -4.1M Q3 '24: -4.8M Q4 '24: -5.1M Q1 '25: -5.1M Q2 '25: -5.1M Q3 '25: -5.4M Q4 '25: -4.8M Q1 '26: -4.8M Q2 '26: -4.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '16: -4.2M Q4 '16: -5.9M Q1 '17: -43.7M Q2 '17: -31.3M Q3 '17: -29.8M Q4 '17: -29.7M Q1 '18: 7.6M Q2 '18: -4.9M Q3 '18: -5.7M Q4 '18: -6.6M Q1 '19: -7.4M Q2 '19: -8.2M Q3 '19: -7.3M Q4 '19: -6M Q1 '20: -5.4M Q2 '20: -4.1M Q3 '20: -3.8M Q4 '20: -3.5M Q1 '21: -4M Q2 '21: -4.3M Q3 '21: -4.9M Q4 '21: -5.2M Q1 '22: -4.6M Q2 '22: -4.8M Q3 '22: -4.4M Q4 '22: -4.4M Q1 '23: -4.4M Q2 '23: -4M Q3 '23: -4M Q4 '23: -3.8M Q1 '24: -4M Q2 '24: -4.3M Q3 '24: -4.9M Q4 '24: -5.1M Q1 '25: -4.7M Q2 '25: -4.7M Q3 '25: -5.2M Q4 '25: -4.5M Q1 '26: -4.5M Q2 '26: -4.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 150K 300K 450K Q3 '15: 201K Q4 '15: 152K Q1 '16: 180.9K Q2 '16: 118.4K Q3 '16: 136.9K Q4 '16: 175.4K Q1 '17: 158.3K Q2 '17: 278.8K Q3 '17: 249.1K Q4 '17: 323.6K Q1 '18: 333.1K Q2 '18: 219.4K Q3 '18: 232K Q4 '18: 171K Q1 '19: 141K Q2 '19: 118.3K Q3 '19: 120K Q4 '19: 81.7K Q1 '20: 101.8K Q2 '20: 98.9K Q3 '20: 93.2K Q4 '20: 95.9K Q1 '21: 73.6K Q2 '21: 47.9K Q3 '21: 32.4K Q4 '21: 5.9K Q1 '22: 6.8K Q2 '22: 7.7K Q3 '22: 9K Q4 '22: 15.3K Q1 '23: 22.4K Q2 '23: 30.1K Q3 '23: 31.6K Q4 '23: 36K Q1 '24: 29K Q2 '24: 18.6K Q3 '24: 14.7K Q4 '24: 1.7K Q1 '25: 0 Q2 '25: 0 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25

Operating Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '16: -1.1M Q4 '16: -2M Q1 '17: -2.6M Q2 '17: -2.6M Q3 '17: -2.6M Q4 '17: -2.5M Q1 '18: -2.1M Q2 '18: -1.8M Q3 '18: -1.7M Q4 '18: -1.8M Q1 '19: -1.7M Q2 '19: -2.1M Q3 '19: -2.5M Q4 '19: -2.9M Q1 '20: -3.3M Q2 '20: -2.9M Q3 '20: -2.7M Q4 '20: -2.2M Q1 '21: -2.4M Q2 '21: -3.2M Q3 '21: -3.2M Q4 '21: -3.5M Q1 '22: -3.5M Q2 '22: -2.5M Q3 '22: -2.2M Q4 '22: -2M Q1 '23: -1.6M Q2 '23: -1.8M Q3 '23: -1.8M Q4 '23: -1.9M Q1 '24: -1.8M Q2 '24: -1.4M Q3 '24: -1.4M Q4 '24: -1.1M Q1 '25: -1.4M Q2 '25: -1.4M Q3 '25: -1.7M Q4 '25: -2.3M Q1 '26: -2M Q2 '26: -2.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '14: 167.2K Q4 '16: -2.3M Q2 '19: -2.1M Q3 '19: -2.6M Q4 '19: -3.1M Q4 '14 Q4 '16 Q2 '19 Q3 '19 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q2 '10: 362M Q3 '10: 95.4M Q1 '11: 37M Q2 '11: 37M Q3 '11: 37M Q1 '12: 118.1M Q2 '12: 105.3M Q3 '12: 100.9M Q2 '13: 116.6M Q3 '13: 117.8M Q1 '14: 20.6M Q2 '14: 142M Q3 '14: 143.5M Q1 '15: 19.8M Q2 '15: 151.8M Q1 '16: 25.5M Q1 '17: 355.9M Q2 '17: 579.7M Q1 '18: 1.8M Q2 '18: 250.5M Q1 '19: 2.4M Q1 '20: 1.1M Q1 '21: 1.1M Q1 '22: 1.1M Q1 '23: 1.8M Q1 '24: 2.9M Q2 '24: 9.5M Q3 '24: 10.9M Q1 '25: 15.1M Q2 '25: 17M Q3 '25: 18.2M Q1 '26: 25.6M Q2 '26: 29.2M Q1 '11 Q3 '12 Q3 '14 Q2 '17 Q1 '21 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: -0.01 Q1 '12: -0.01 Q2 '12: -0.01 Q3 '12: -0.01 Q4 '12: 0.00 Q1 '13: 0.00 Q2 '13: 0.00 Q3 '13: 0.00 Q4 '13: -0.03 Q1 '15: -0.01 Q2 '15: -0.03 Q3 '15: -0.03 Q4 '15: -0.02 Q1 '16: -0.02 Q2 '16: -0.01 Q3 '16: -0.03 Q4 '16: -0.03 Q1 '17: -0.22 Q2 '17: -0.19 Q3 '17: -0.17 Q4 '17: -12.82 Q1 '18: -13.04 Q2 '18: -13.06 Q3 '18: -13.81 Q4 '18: -2.10 Q1 '19: -2.36 Q2 '19: -3.03 Q3 '19: -2.61 Q4 '19: -1.72 Q1 '25: -0.41 Q2 '25: -0.35 Q3 '25: -0.32 Q4 '25: -0.19 Q1 '26: -0.16 Q2 '26: -0.12 Q3 '11 Q4 '12 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.